Targeted Degradation of Structured RNAs via Ribonuclease-Targeting Chimeras (RiboTacs).

Haj-Yahia, Salma; Nandi, Arijit; Benhamou, Raphael I

Haj-Yahia, Salma; Nandi, Arijit; Benhamou, Raphael I.

Afiliación

Haj-Yahia S; The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nandi A; The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Benhamou RI; The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Expert Opin Drug Discov ; 18(8): 929-942, 2023.

Article en En | MEDLINE | ID: mdl-37306675

Asunto(s)

ARN; Ribonucleasas; Ribonucleasas/metabolismo; ARN/química; ARN/metabolismo; Descubrimiento de Drogas; Proteínas/metabolismo

Palabras clave

RNA; RNase L; RiboTaC; Targeted degradation; Therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleasas / ARN Idioma: En Revista: Expert Opin Drug Discov Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleasas / ARN Idioma: En Revista: Expert Opin Drug Discov Año: 2023 Tipo del documento: Article